As the current opioid addiction/overdose epidemic spread out across America over the last 20 years, it wasn’t just greedy drugstore chains that turned a blind eye to fake and questionable prescriptions. A new report highlights how the company behind one of the epidemic’s signature drugs ignored warning signs of obvious illegal activity. [More]
When OxyContin hit pharmacies 20 years ago, its primary selling point was that a single dose of the opioid pain medication lasted 12 hours, “providing smooth and sustained pain control all day and all night,” per the press release. But a new report claims Purdue Pharma, the makers of OxyContin, have long known that the drug doesn’t always live up to this promise, resulting in an increased likelihood for abuse and addiction. [More]
Earlier this summer, the Drug Enforcement Agency slapped Walgreens with a substantial $80 million settlement over allegations that the drugstore chain had allowed an ocean of prescription painkillers to hit the black market in Florida. Now, between revelations from the local police and uncovered DEA documents, the public is finally getting an idea of just how bad the problem was, and how much Walgreens turned a blind eye to illegal activity at its stores. [More]
The U.S. Food and Drug Administration doesn’t want to make it too easy for people who might abuse the powerful painkiller OxyContin, and has such has declared that generic drug manufacturers cannot produce their own, crushable versions of the drug.
The company that makes OxyContin has a good thing going, with lots of free PR from shows like Intervention and Justified and no exact generic equivalent to undercut its market share. But there are dark clouds on the horizon for the OxyContin brand, as its patent is set to expire in April. Now, in a ploy to extend that patent, the Oxy folks are going through the motions of pretending they actually care whether or not children can take the drug safely.
Too many doctors are writing unnecessary prescriptions for painkillers like OxyContin and fentanyl, says the White House. That’s why the administration is looking to push through legislation that would require training for physicians who wish to write prescriptions for these drugs.
In response to the epidemic of opiate addiction, Purdue Phrama LP the maker of Oxycontin, has developed a new version of the powerful painkiller that’s “harder to abuse.” According to an AP article, the government will soon be examining this new incarnation of the drug and evaluating the manufacturer’s lofty claims. How could this drug be made “abuse-resistant?” Details, inside…
“They justify it because they’re having a hard time financially,” he said. “Left to ourselves, we can justify anything, but they’re really part of the problem.”
Of course the real question is: Are these Grandmothers of Slangin’ maximizing their profits by buying from discount overseas pharmacies? And if so, which ones, and can we get their domain names?